Perspective Therapeutics, Inc. - COMMON STOCK (CATX)

151 filings reported holding CATX - Perspective Therapeutics, Inc. - COMMON STOCK as of Q1 2025.
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 44,107,303 shares of 73,943,049 outstanding shares and own 59.65% of the company stock.
Largest 10 shareholders include FMR LLC (10,050,739 shares), BlackRock, Inc. (3,971,525 shares), VANGUARD GROUP INC (3,067,051 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,829,413 shares), Octagon Capital Advisors LP (2,250,000 shares), Affinity Asset Advisors, LLC (2,224,196 shares), Avidity Partners Management LP (2,197,270 shares), Nicholson Wealth Management Group, LLC (1,609,283 shares), MORGAN STANLEY (1,558,451 shares), and Nuveen, LLC (1,242,542 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.